ContractClinical Evaluation Agreement • December 12th, 2017
Clinical Evaluation Agreement Smlouva o klinickém hodnocení C Tato smlouva se uzavírá mezi smluvními stranami: - TFS Trial Form Support, s.r.o., Klimentská 1216/46, 110 02 Praha 1, Czech Republic, entered in Business Register at Municipal Court in Prague, section C, inset 123492 under ID: 278 76 756 (hereinafter "TFS”), represented by Carlos Rodriguez Vicepresident Finance,TFS. – TFS Trial Form Support, s.r.o., Klimentská 1216/46, Praha 1, Česká republika, zapsaná v obchodním rejstříku vedeném Městským soudem v Praze, oddíl C, vložka 123492, IČO: 278 76 756 (dále jen„TFS“), zastoupená Carlos Rodriguez, Vicepresident Finance TFS. TFS Trial Form Support International AB, having its registered office at Scheelevägen 8B, Byggnad 1601, 223 63 Lund, Sweden, ID 556531-1660, together with each of its subsidiaries and affiliates collectively, including TFS, has been commissioned by Novartis Pharma Services AG having its registered address at Lichtstrasse 35, CH-4056 Basel, Switzerland, ID CHE
CONTRACT AMENDMENT # 1 DODATEK Č. 1 KE SMLOUVĚ OClinical Evaluation Agreement • October 10th, 2019
(“Contract Amendment # 1”) is made and become effective as of the day the last party to subscribe below and the Agreement will be published in the Contract Register by the statutory deadline (the “Effective Date”), is by and between
